Zura is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases with unmet need. Zura’s pipeline includes product candidates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results